Brief: Aroa Biosurgery Says FY23 Product Revenue Guidance Maintained At NZ$51-55 Mln
26/07/2022 02:29
July 26 (Reuters) - Aroa Biosurgery Ltd ARX.AX :
* FY23 PRODUCT REVENUE GUIDANCE MAINTAINED AT NZ$51-55
MILLION
Source text for Eikon: ID:nASXXQ0YZ
Further company coverage: ARX.AX
Recent news on Aroa Biosurgery
See all newsAustralia-listed Aroa Biosurgery climbs as annual earnings beat guidance
Brief: Aroa Biosurgery Posts Adjusted EBITDA Of NZ$12.6 Million
Aroa Biosurgery climbs as prelim annual results beat outlook
Brief: Aroa Biosurgery Posts FY26 Prelim Total Revenue Of NZ$104 Million
Brief: Aroa Biosurgery Says Expects FY26 Revenue At Upper End Of NZ$92-100 Million